Pixium Vision S.A.
Created in 2011
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
1,865 5,018Activities
Technologies
Entity types
Location
74 Rue du Faubourg Saint-Antoine, 75012 Paris, France
Paris
France
Employees
Scale: 11-50
Estimated: 16
SIREN
538797655Engaged corporates
10
7 3Added in Motherbase
6 years, 3 months ago
healthtech Value proposition
Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons !
One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission of Pixium Vision.
Two novel life changing Bionic Vision Systems developed, with active implantable prostheses, that are intended to compensate for vision loss and blindness from retinal degeneration, like Dry Age-Related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP), enabling to regain partial central visual perception and lead more independent lives.
Advances in neuro-ophthalmology, innovative state of the art biomedical / bioelectronic technologies, smart bio-inspired bio-mimetic algorithms and AI, and miniaturization of micro/nano-electronics, enable minimal invasive retinal surgery, and develop systems that could provide blind people with a form of prosthetic bionic vision.
• PRIMA (Subretinal) a miniaturized wireless photovoltaic implant platform initially for Dry-AMD. The company is conducting first-in-human feasibility trials in Europe and the US.
• IRIS®II (Epiretinal) its first System for RP, equipped with a bio-inspired camera, an implant with 150 electrodes, designed to be explantable.
Formed in Dec 2011, a bioelectronics technology company specialized in neuromodulation to restore a form of prosthetic vision to compensate for blindness. Listed on Euronext Paris stock exchange in June 2014. Collaborates with a global ecosystem of scientific and clinical partners spanning the prestigious Vision research institutions including: Institut de la Vision Paris, Stanford University California, Moorfields Eye Hospital London, and Institute of Ocular Microsurgery (IMO) Barcelona.
twitter: @PixiumVision
Ophthalmology, Retina, Bionic Vision, Neuromodulation, Neuroscience, Neurobiology, Artificial Vision, Neuro Opthalmology, Bio hacking, Neuro Ophthalmodulation, Artificial Vision, retinitis pigmentosa, blindness, ophtalmologie, vision restoration, bio electric, Age related Macular Degeneration AMD, bio electronic medicine, Digital Medicine, Sensory Neuromodulation, Bbioelectronics, and Dry AMDOriginal language
Innovating at the frontier of neuroscience : brain machine interfacing the Eye and the Brain - from photons to neurons !
One must remember the notion that restoring some vision to those who have lost their sight is possible, has long been thought to be fanciful. However, we are in the Age of Neural Prostheses, Bioelectronics, and BMI. At frontier of neuroscience, interfacing the worlds of eye and the brain – “from Photons to Neurons”. Such is the breadth and depth of knowledge needed to build a world of bionic vision for those with vision loss. This is the mission of Pixium Vision.
Two novel life changing Bionic Vision Systems developed, with active implantable prostheses, that are intended to compensate for vision loss and blindness from retinal degeneration, like Dry Age-Related Macular Degeneration (AMD) and Retinitis Pigmentosa (RP), enabling to regain partial central visual perception and lead more independent lives.
Advances in neuro-ophthalmology, innovative state of the art biomedical / bioelectronic technologies, smart bio-inspired bio-mimetic algorithms and AI, and miniaturization of micro/nano-electronics, enable minimal invasive retinal surgery, and develop systems that could provide blind people with a form of prosthetic bionic vision.
• PRIMA (Subretinal) a miniaturized wireless photovoltaic implant platform initially for Dry-AMD. The company is conducting first-in-human feasibility trials in Europe and the US.
• IRIS®II (Epiretinal) its first System for RP, equipped with a bio-inspired camera, an implant with 150 electrodes, designed to be explantable.
Formed in Dec 2011, a bioelectronics technology company specialized in neuromodulation to restore a form of prosthetic vision to compensate for blindness. Listed on Euronext Paris stock exchange in June 2014. Collaborates with a global ecosystem of scientific and clinical partners spanning the prestigious Vision research institutions including: Institut de la Vision Paris, Stanford University California, Moorfields Eye Hospital London, and Institute of Ocular Microsurgery (IMO) Barcelona.
twitter: @PixiumVision
Pixium | Science Corporation
Science Corporation is a clinical-stage medical technology company.
https://science.xyz/company/pixium/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Banque des Territoires Bank, Banking | Banque des Territoires Bank, Banking | Other 8 Feb 2020 | | |
 Euronext Finance, Financial Services | Euronext Finance, Financial Services | Not capitalistic Not partnership Event 18 Jun 2014 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Not capitalistic Not partnership Event 10 Oct 2019 | | |
 STATION F Startup accelerator & VC, Software Development | STATION F Startup accelerator & VC, Software Development | Other 15 Mar 2019 | | |
 L'Oréal Cosmetics, Personal Care Product Manufacturing | L'Oréal Cosmetics, Personal Care Product Manufacturing | Not capitalistic Not partnership Event 26 Sep 2016 | | |
 Societe Generale Bank, Banking | Societe Generale Bank, Banking | Other 6 Apr 2016 | | |
 Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Not capitalistic Partnership Not event 14 Nov 2018 | | |
 Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Fondation Adolphe de Rothschild NGO, Think Tank, Hospitals and Health Care | Not capitalistic Not partnership Event 22 Nov 2018 | | |
 Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Not capitalistic Partnership Not event 6 Jul 2020 29 Sep 2023 | | |
 Omnes Startup accelerator & VC, Financial Services | Omnes Startup accelerator & VC, Financial Services | Not capitalistic Partnership Event 10 Sep 2018 | | |